Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1517514
PUBLISHER: BCC Research | PRODUCT CODE: 1517514
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
The global market for radiopharmaceuticals is expected to grow from $9.9 billion in 2024 and is projected to reach $21.0 billion by the end of 2029, at a CAGR of 16.2% during the forecast period of 2024 to 2029.
The global market for radiation therapy products and services is expected to grow from $7.5 billion in 2024 and is projected to reach $10.2 billion by the end of 2029, at a CAGR of 6.3% during the forecast period of 2024 to 2029.
Report Scope
This report analyzes the global market for radiation therapy products (systems, software and services) and radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers develop assess the market, business/growth strategies, and make informed business decisions regarding radiation therapy products and services and radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and forecasts values for 2024 through 2029.
Radiation therapy market segmentation is based on product, technology, techniques, system type, application and region. Radiopharmaceuticals market segmentation is based on product, application, production method and region.
Industry growth drivers, restraints and opportunities in the radiation therapy and radiopharmaceutical market are also discussed. The report also reports on the competitive landscape of radiation therapy products, radiopharmaceutical markets and emerging trends. The latest new products, acquisitions, and collaborations related to the radiation therapy and radiopharmaceutical markets are also covered.
Report Includes
- 51 data tables and 39 additional tables
- An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
- Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2025, and projected CAGRs through 2029
- Identification of new opportunities, challenges and technological changes in the industry and a market share analysis by segment, product type, technology type, application, production method, and region
- Examination of the present and future strategies of companies in the market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
- Discussion of the applications for positron emission tomography (PET) and single photon emission computed tomography (SPECT)
- Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
- Analysis of the current market trends and forecast, R&D activity, product launches and regulatory elements
- Analysis of the key companies' market shares, mergers & acquisitions, joint ventures and collaborations
- Profiles of the major players in the market, including Accuray Inc., Cardinal Health, Elekta, Novartis AG, and Siemens Healthineers AG
Product Code: HLC176E
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Radiopharmaceuticals
- Radiation Therapy
Chapter 3 Market Dynamics
- Radiotherapy Market Drivers
- Rising Prevalence of Cancer
- Early Screening
- Advances in Radiation Therapy Planning and Delivery Systems
- Increasing Demand in Developing Regions
- Applications Beyond Oncology
- Radiotherapy Market Restraints
- Shortage of Skilled Professionals
- Limited Effectiveness against Metastatic Cancer
- Trends in Radiotherapy Market
- Growing Use of Advanced Imaging and Hypofractionation
- Adaptive Radiation Therapy
- Radiopharmaceutical Market Drivers
- Rising Prevalence of Chronic Diseases
- Focus on Early Diagnosis and Screening
- Precision Medicine
- Nuclear Imaging Technologies
- Increasing Investments
- Radiopharmaceutical Market Restraints
- Manufacturing and Supply Chain Issues
- Infrastructure and Specialized Imaging Equipment Requirements
- Trends in the Radiopharmaceutical Market
- Theranostics
- PET/MRI Hybrid Imaging
Chapter 4 Emerging Technologies and Developments
- Emerging Technologies in Radiation Therapy
- Artificial Intelligence
- Online Adaptive Radiation Therapy
- MR-Linac
- FLASH Radiation Therapy
- Emerging Technologies in Radiopharmaceuticals
- Targeted Alpha Therapy
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Radiation Therapy Market, by Product Type
- Market Overview
- Market Size and Forecast
- Radiation Therapy Market, by Technology Type
- Market Size and Forecast
- External Beam Radiation Therapy
- EBRT by Technique Type
- EBRT, by System Type
- EBRT, by Application
- Internal Beam Radiation Therapy
- IBRT, by Technique Type
- IBRT, by Product Type
- IBRT, by Application
- Radiation Therapy Market, by Region
- Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of the World (Row)
- Radiopharmaceuticals Market, by Product Type
- Market Size and Forecast
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Radiopharmaceuticals Market, by Application
- Market Size and Forecast
- Oncology
- Cardiology
- Neurology
- Other Applications
- Radiopharmaceuticals Market, by Production Method
- Market Overview
- Nuclear Reactors
- Cyclotrons
- Radionuclide Generators
- Market Size and Forecast
- Geographic Breakdown
- Radiopharmaceuticals Market, by Region
- Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- RoW
Chapter 6 Competitive Intelligence
- Leading Radiotherapy Device Manufacturers
- Leading Companies in Radiopharmaceuticals
Chapter 7 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- ACCURAY INC.
- CARDINAL HEALTH
- CURIUM
- ELEKTA
- GE HEALTHCARE
- LANTHEUS
- NOVARTIS AG
- SIEMENS HEATHNIEERS AG
Product Code: HLC176E
List of Tables
- Summary Table : Global Market for Radiation Therapy Products and Radiopharmaceuticals, by Type, Through 2029
- Table 1 : Acquisitions and Funding in the Radiopharmaceuticals Market
- Table 2 : Comparison of CT and MRI for Radiotherapy Treatment
- Table 3 : Targeted Alpha Therapies in Development, 2024
- Table 4 : Global Market for Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 5 : Global Market for Radiation Therapy Products and Services, by Technology Type, Through 2029
- Table 6 : Global Market for EBRT Products and Services, by Technique Type, Through 2029
- Table 7 : Specialized Stereotactic Radiosurgery Systems
- Table 8 : Global Market for EBRT Products and Services, by System Type, Through 2029
- Table 9 : Global Market for Particle Therapy Products and Services, by System Type, Through 2029
- Table 10 : Global Market for EBRT Products and Services, by Application, Through 2029
- Table 11 : Estimated Number of New Cancer Cases, by Cancer Site, 2022-2045
- Table 12 : Commonly Used Radionuclides (Radiation Sources) Half-Life for Brachytherapy
- Table 13 : Global Market for Internal Radiation Therapy Products and Services, by Technique Type, Through 2029
- Table 14 : Global Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 15 : Estimated New Cancer Cases, by Cancer Site, 2022-2045
- Table 16 : Global Market for Internal Beam Radiation Therapy Products and Services, by Application, Through 2029
- Table 17 : Global Market for Radiation Therapy Products and Services, by Region, Through 2029
- Table 18 : North American Market for Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 19 : North American Market for Radiation Therapy Products and Services, by Country, Through 2029
- Table 20 : North American Market for Radiotherapy Products and Services, by Technology Type, Through 2029
- Table 21 : North American Market for EBRT Products and Services, by System Type, Through 2029
- Table 22 : North American Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 23 : European Market for Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 24 : European Market for Radiation Therapy Products and Services, by Country, Through 2029
- Table 25 : European Market for Radiotherapy Products and Services, by Technology Type, Through 2029
- Table 26 : European Market for EBRT Products and Services, by System Type, Through 2029
- Table 27 : European Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 28 : Asia-Pacific Market for Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 29 : Asia-Pacific Market for Radiation Therapy Products and Services, by Country, Through 2029
- Table 30 : Asia-Pacific Market for Radiotherapy Products and Services, by Technology Type, Through 2029
- Table 31 : Asia-Pacific Market for EBRT Products and Services, by System Type, Through 2029
- Table 32 : Asia-Pacific Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 33 : Global Cancer Incidence, by Region, 2022 and 2045
- Table 34 : RoW Market for Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 35 : RoW Market for Radiation Therapy Products and Services, by Subregion, Through 2029
- Table 36 : RoW Market for Radiotherapy Products and Services, by Technology Type, Through 2029
- Table 37 : RoW Market for EBRT Products and Services, by System Type, Through 2029
- Table 38 : RoW Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
- Table 39 : Global Market for Radiopharmaceuticals, by Product Type, Through 2029
- Table 40 : Radioisotopes Used in Diagnostic Radiopharmaceuticals
- Table 41 : Comparison of PET and SPECT
- Table 42 : FDA-approved PET Radiopharmaceuticals
- Table 43 : FDA-approved SPECT and Other Diagnostic Radiopharmaceuticals
- Table 44 : Global Market for Diagnostic Radiopharmaceuticals, by Product Type, Through 2029
- Table 45 : Comparison of Alpha and Beta Particles
- Table 46 : FDA-approved Therapeutic Radiopharmaceuticals
- Table 47 : Global Market for Therapeutic Radiopharmaceuticals, by Product Type, Through 2029
- Table 48 : Global Market for Radiopharmaceuticals, by Application, Through 2029
- Table 49 : Radiopharmaceuticals for CNS Imaging in Clinical Development
- Table 50 : Global Market for Radiopharmaceuticals, by Production Method, Through 2029
- Table 51 : Global Market for Radiopharmaceuticals, by Region, Through 2029
- Table 52 : North American Market for Radiopharmaceuticals, by Product Type, Through 2029
- Table 53 : European Market for Radiopharmaceuticals, by Product Type, Through 2029
- Table 54 : Asia-Pacific Market for Radiopharmaceuticals, by Product Type, Through 2029
- Table 55 : RoW Market for Radiopharmaceuticals, by Product Type, Through 2029
- Table 56 : Rank of Companies in the Global Radiopharmaceuticals Market, 2023
- Table 57 : Report Sources
- Table 58 : Abbreviations Used in This Report
- Table 59 : Accuray Inc.: Company Snapshot
- Table 60 : Accuray Inc.: Financial Performance, FY 2022 and 2023
- Table 61 : Accuray Inc.: Product Portfolio
- Table 62 : Accuray Inc.: News/Key Developments, 2022 and 2023
- Table 63 : Cardinal Health: Company Snapshot
- Table 64 : Cardinal Health: Financial Performance, FY 2022 and 2023
- Table 65 : Cardinal Health: Product Portfolio
- Table 66 : Cardinal Health: News/Key Developments, 2021
- Table 67 : Curium: Company Snapshot
- Table 68 : Curium: Product Portfolio
- Table 69 : Curium: News/Key Developments, 2022 and 2023
- Table 70 : Elekta: Company Snapshot
- Table 71 : Elekta: Financial Performance, FY 2021 and FY 2022
- Table 72 : Elekta: Product Portfolio
- Table 73 : Elekta: News/Key Developments, 2021-2023
- Table 74 : GE HealthCare: Company Snapshot
- Table 75 : GE HealthCare: Financial Performance, FY 2022 and 2023
- Table 76 : GE HealthCare: Product Portfolio
- Table 77 : GE HealthCare: News/Key Developments, 2021-2023
- Table 78 : Lantheus: Company Snapshot
- Table 79 : Lantheus: Financial Performance, FY 2022 and 2023
- Table 80 : Lantheus: Product Portfolio
- Table 81 : Lantheus: News/Key Developments, 2022 and 2023
- Table 82 : Novartis AG: Company Snapshot
- Table 83 : Novartis AG: Financial Performance, FY 2022 and 2023
- Table 84 : Novartis AG: Product Portfolio
- Table 85 : Novartis AG: News/Key Developments, 2022 and 2023
- Table 86 : Siemens Healthineers AG: Company Snapshot
- Table 87 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
- Table 88 : Siemens Healthineers AG: Product Portfolio
- Table 89 : Siemens Healthineers AG: News/Key Developments, 2022-2024
List of Figures
- Summary Figure : Global Market for Radiation Therapy Products and Radiopharmaceuticals, by Type, 2021-2029
- Figure 1 : Types of Radiation
- Figure 2 : Radiation Therapy and Radiopharmaceuticals Market Dynamics
- Figure 3 : Estimated New Cancer Cases, 2022, 2045 and 2050
- Figure 4 : Cancer Radiotherapy Treatment Systems, by Region, 2021
- Figure 5 : Global Incidence of Cancer, by Region, 2022 and 2045
- Figure 6 : Global Market Shares of Radiation Therapy Products and Services, by Product Type, 2023
- Figure 7 : Global Market Shares of Radiation Therapy Products and Services, by Technology Type, 2023
- Figure 8 : Global Market Shares of EBRT Products and Services, by Technique Type, 2023
- Figure 9 : Global Market Shares of EBRT Products and Services, by System Type, 2023
- Figure 10 : Global Market Shares of Particle Therapy Products and Services, by System Type, 2023
- Figure 11 : Global Market Shares of EBRT Products and Services, by Application, 2023
- Figure 12 : Global Market Shares of Internal Radiation Therapy Products and Services, by Technique Type, 2023
- Figure 13 : Global Market Shares of Internal Radiation Therapy Products and Services, by Product Type, 2023
- Figure 14 : Global Market Shares of Internal Radiation Therapy Products and Services, by Application, 2023
- Figure 15 : Global Market for Radiation Therapy Products and Services, by Region, 2021-2029
- Figure 16 : Global Market Shares of Radiation Therapy Products and Services, by Region, 2023
- Figure 17 : Global Market Shares of Radiopharmaceuticals, by Product Type, 2023
- Figure 18 : Global Market Shares of Diagnostic Radiopharmaceuticals, by Product Type, 2023
- Figure 19 : Global Market Shares of Therapeutic Radiopharmaceuticals, by Product Type, 2023
- Figure 20 : Global Market Shares of Radiopharmaceuticals, by Application, 2023
- Figure 21 : Global Market Shares of Radiopharmaceuticals, by Production Method, 2023
- Figure 22 : Global Market Shares of Radiopharmaceuticals, by Region, 2023
- Figure 23 : North American Market Shares of Radiopharmaceuticals, by Product Type, 2023
- Figure 24 : European Market Shares of Radiopharmaceuticals, by Product Type, 2023
- Figure 25 : Asia-Pacific Market Shares of Radiopharmaceuticals, by Product Type, 2023
- Figure 26 : RoW Market Shares of Radiopharmaceuticals, by Product Type, 2023
- Figure 27 : Global Market Shares of Radiation Therapy Devices, by Company, 2023
- Figure 28 : Global Market Shares of Radiopharmaceuticals, by Company, 2023
- Figure 29 : Accuray Inc.: Revenue Shares, by Business Unit, FY 2023
- Figure 30 : Accuray Inc.: Revenue Shares, by Country/Region, FY 2023
- Figure 31 : Cardinal Health: Revenue Shares, by Business Unit, FY 2023
- Figure 32 : Cardinal Health: Revenue Shares, by Country/Region, FY 2023
- Figure 33 : Elekta: Revenue Shares, by Business Unit, FY 2022
- Figure 34 : Elekta: Revenue Shares, by Country/Region, FY 2022
- Figure 35 : GE HealthCare: Revenue Shares, by Business Unit, FY 2023
- Figure 36 : GE HealthCare: Revenue Shares, by Country/Region, FY 2023
- Figure 37 : Lantheus: Revenue Shares, by Business Unit, FY 2023
- Figure 38 : Novartis AG: Revenue Shares, by Business Unit, FY 2023
- Figure 39 : Novartis AG: Revenue Shares, by Country/Region, FY 2023
- Figure 40 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023
- Figure 41 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.